Use of the Atalante exoskeleton
DeviceA session basically includes a stand up, walks over a distance of 10 meters, exercises, U-turns and a sitting
NCT Number: NCT04110561
The study is a prospective, open, bicentric and observational study. It is conducted to assess the safety and performance of the Atalante exoskeleton system with patients with lower limb paralysis.
The principal objective is to assess the performance of the Atalante system in performing ambulatory functions with motor complete SCI patients characterized by the success rate in performing a 10mWT at the last session of training with the Atalante system.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Centre Jacques Calvé - Fondation Hopale, Berck, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A session basically includes a stand up, walks over a distance of 10 meters, exercises, U-turns and a sitting
Time frame: At study completion, up to 3 weeks
The 10mWT is used to assess walking speed in meters/second (m/s) over a short distance.
A clear pathway of at least 10-meter length is drawn. The start and the end point of a 10-m walkway is marked by lines.
The patient starts a few steps prior the starting line; during the few steps needed to reach the starting line, the physiotherapist should stabilize the exoskeleton in the frontal plane. When the patient's first foot crosses the starting line, the test begins, and the stopwatch is started. The stopwatch is stopped at the end of the 10 meters in case of success, that is to say when the patient crosses the end line.
The total time taken to ambulate is recorded. The distance covered is then divided by the total time (in seconds) taken to ambulate and recorded in meters per seconds.
In case of failure, the distance walked by the patient is measured and recorded, and the speed to walk this distance is calculated as described above.
Time frame: At study mid-term, 10 days in average
Time frame: At study mid-term, 10 days in average and at study completion, up to 3 weeks
Time frame: At study mid-term, 10 days in average and at study completion, up to 3 weeks
Time frame: At study mid-term, 10 days in average and at study completion, up to 3 weeks
Time frame: At study mid-term, 10 days in average and at study completion, up to 3 weeks
Time frame: At study mid-term, 10 days in average and at study completion, up to 3 weeks
Time frame: At study mid-term, 10 days in average and at study completion, up to 3 weeks
Time frame: At study mid-term, 10 days in average and at study completion, up to 3 weeks
Time frame: At study mid-term, 10 days in average and at study completion, up to 3 weeks
Rating of perceived exertion (RPE) is a widely used and reliable indicator to monitor and guide exercise intensity.
The scale allows individuals to subjectively rate their level of exertion during exercise or exercise testing.
Developed by Gunnar Borg, it is often also referred to as the Borg Scale. Despite being a subjective measure of exercise intensity, RPE scales provide valuable information when used correctly.
The revised category-ratio scale (0 to 10 scale) is used:
Time frame: At study mid-term, 10 days in average and at study completion, up to 3 weeks
A Likert scale is a psychometric scale commonly involved in research based on survey questionnaires. Here, the respondents specify their level of agreement or disagreement using a symmetric agree-disagree scale for a series of statements while responding to a particular Likert questionnaire item. The range of Likert scale captures the intensity of their feelings for a given item.
The Likert scale ratings are:
The perceived safety is evaluated with the 7-point Likert scale on the following statement:
"I felt safe during the test"
Time frame: Throughout study completion, an average of 3 weeks
Time frame: At study start, day 1 and at study completion, up to 3 weeks
The neurogenic bowel dysfunction score is a questionnaire including questions about background parameters, faecal incontinence, constipation, obstructed defecation, and impact on quality of life. The NBD score is constructed from items with acceptable reproducibility and validity that were significantly associated with impact on quality of life. The type of the stool depends on the time it spends in the colon.
Time frame: At study start, day 1 and at study completion, up to 3 weeks
The Bristol Stool Chart is:
Type 1, 2 and 3 indicate constipation. Type 4 and 5 are ideal stools. Type 6 and 7 indicate diarrhea and urgency.
Time frame: At study start, day 1 and at study completion, up to 3 weeks
The management of neurogenic bladder dysfunction is crucial in the management of paraplegic patients as it affects the morbidity of these patients. The voiding mode is described. The self-survey is the standard treatment when the subject has an overactive bladder. The mictionnel mode will be informed before the first session, and at the end of the last session with the exoskeleton using an ISCOS questionnaire (International Spinal Cord Society questionnaire).
Time frame: At study start, day 1 and at study completion, up to 3 weeks
The Qualiveen score is developed as a condition-specific quality of life measurement for individuals with SCI who have urinary disorders. It contains 4 domains:
The test-retest reliability is high6.
Time frame: At study start, day 1 and at study completion, up to 3 weeks
The Modified Ashworth Scale measures spasticity in patients with lesion of the Central Nervous System. The relationship between the raters' judgments was significant and the reliability was good. (PMID: 3809245)
The scoring is:
Muscles evaluated are adductor, hamstring, triceps sural and quadriceps.
Time frame: At study start, day 1, at study mid-term, 10 days and at study completion, up to 3 weeks
Time frame: At study start, day 1 and at study completion, up to 3 weeks
The Numeric Pain Rating Scale measures the subjective intensity of pain. The NPRS is an 11-points scale from 0 to 10: "0" = no pain; "10" = the most intense pain imaginable.
The subject is asked to make pain rating corresponding to the current pain experienced.
Time frame: At study start, day 1 and at study completion, up to 3 weeks
NPSI (Neuropathic Pain Sumptom Inventory) renders it suitable for the evaluation of the different dimensions of neuropathic pain syndromes. The reliability of the different descriptors appears to be sufficient.
It allows to quantify the various pain symptoms that can be grouped into five dimensions (burn, deep pain, paroxysmal pain, pain caused, paresthesia / dysesthesia)
Time frame: At study completion, up to 3 weeks
The Patient Global Impression of Improvement (PGI-I) is a global index that may be used to rate the response of the use of Atalante on the bowel function.
The subject should check the number that best describes how the twelfth session condition is, compared with how it has been at the first session for the bowel function:
Time frame: At study completion, up to 3 weeks
At the end of the twelfth session, the patient evaluates the interfaces and the ergonomics of Atalante (shape of the remote, mode, symbol) and the perceived safety and the level of assistance during transfer from the wheelchair to Atalante with a Likert scale.
The Likert scale is a questionnaire where the subject chooses among seven-point scales:
Time frame: At study completion, up to 3 weeks
Time frame: At study completion, up to 3 weeks
The level of assistance is specified for each attachment (thigh, knee and foot straps). The levels of assistance are:
Time frame: At study completion, up to 3 weeks
At the end of the twelfth session, the strapping system is evaluated using a 7-point Likert scale:
Time frame: At study start, day 1 and at study completion, up to 3 weeks
This test evaluates the ability of the subject to balance in sitting position during disturbances induced by movements of the upper limbs. The subject is sitting without back's support and with both feet on the ground. The subject is asked to do six tasks from the easiest to the hardest. The subject must pass the task to test the next task. The score is defined by the last passed task. The sitting balance is evaluated at the first and at the last session.
Time frame: Throughout study completion, an average of 3 weeks
Wandercraft
Industry
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04736849
Central Nervous System Diseases, Nervous System Diseases
Rochester, Minnesota, United States
View Trial DetailsNCT05432999
Central Nervous System Diseases, Muscle Hypertonia
West Orange, New Jersey, United States
View Trial DetailsNCT03495986
Behavior, Central Nervous System Diseases
Miami, Florida, United States
View Trial DetailsNCT05776862
Atrophy, Atrophy, Muscular
Miami, Florida, United States
View Trial Details